LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 75.93 | 84.90 | 3623 | 8970 | 0.4039 | 0.7477 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 77.64 | 84.90 | 355 | 9245 | 0.0384 | 0.2354 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 77.64 | 84.90 | 3253 | 9245 | 0.3518 | 0.7139 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 77.64 | 84.90 | 592 | 9245 | 0.0640 | 0.3324 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 77.64 | 84.90 | 3812 | 9245 | 0.4123 | 0.7546 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 79.34 | 84.90 | 395 | 9051 | 0.0436 | 0.2564 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 79.34 | 84.90 | 3350 | 9051 | 0.3701 | 0.7256 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 79.34 | 84.90 | 522 | 9051 | 0.0577 | 0.3095 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 79.34 | 84.90 | 3895 | 9051 | 0.4303 | 0.7647 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 81.05 | 84.90 | 422 | 8863 | 0.0476 | 0.2701 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 81.05 | 84.90 | 3486 | 8863 | 0.3933 | 0.7402 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 81.05 | 84.90 | 571 | 8863 | 0.0644 | 0.3287 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 81.05 | 84.90 | 4053 | 8863 | 0.4573 | 0.7797 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.75 | 84.90 | 447 | 8621 | 0.0518 | 0.2830 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.75 | 84.90 | 3619 | 8621 | 0.4198 | 0.7558 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.75 | 84.90 | 605 | 8621 | 0.0702 | 0.3426 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.75 | 84.90 | 4216 | 8621 | 0.4890 | 0.7965 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 84.45 | 84.90 | 480 | 8254 | 0.0581 | 0.3000 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 84.45 | 84.90 | 3755 | 8254 | 0.4549 | 0.7751 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 84.45 | 84.90 | 591 | 8254 | 0.0716 | 0.3416 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 84.45 | 84.90 | 4239 | 8254 | 0.5135 | 0.8080 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 86.16 | 84.90 | 497 | 8141 | 0.0610 | 0.3079 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 86.16 | 84.90 | 3880 | 8141 | 0.4765 | 0.7871 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 86.16 | 84.90 | 554 | 8141 | 0.0680 | 0.3297 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 86.16 | 84.90 | 4422 | 8141 | 0.5431 | 0.8229 | MN20160318_Q02 | L16 |